792
Participants
Start Date
March 27, 2017
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2027
Irinotecan
every 14 days, 12 cycles, 24 weeks, new cycle beginning on day 15: irinotecan (Campto®) 180 mg/m² on D1, IV infusion over 90 minutes to begin 30 min after folinic acid infusion is started
Folfox Protocol
every 14 days, 12 cycles, 24 weeks, new cycle beginning on day 15: oxaliplatin (Eloxatin®) 85 mg/m² on D1, IV infusion over 2 hours, followed by folinic acid 400 mg/m² (racemic mixture) (or 200 mg/m² if L-folinic acid) IV infusion over 2 hours 5-FU 2400 mg/m²/h IV continuous infusion over 46 hours starting at the end of folinic acid infusion
The PEI Cancer Treatment Centre Queen Elizabeth Hospital, Charlottetown
Hopital Charles LeMoyne, Greenfield Park
Centre hospitalier de l'Université de Montréal, Montreal
Allan Blair Cancer Centre, Regina
Institut de Cancérologie de l'Ouest -site Paul Papin, Angers
CHD de Vendée, La Roche-sur-Yon
Ch Emile Roux, Le Puy-en-Velay
Hospices civils de Lyon - Hôpital Edouard Herriot, Lyon
Hôpital privé Jean Mermoz, Lyon
Icm Val D'Aurelle, Montpellier
Institut de Cancérologie de l'Ouest -site René Gauducheau, Nantes
Hôpital Européen Georges Pompidou, Paris
Hôpital Saint Antoine, Paris
Centre Hospitalier Annecy Genevois, Pringy
Institut Jean Godinot, Reims
CHP Saint Grégoire, Saint-Grégoire
Clinique de la Côte d'Emeraude, St-Malo
Canadian Cancer Trials Group
NETWORK
GONO GROUP
UNKNOWN
UNICANCER
OTHER